honey
The healthcare and life sciences industry is set to witness revolutionary developments over the next decade. Listed below are the top healthcare industry reports by Bizwit Research & Consulting. You can select the topic of your interest and connect to us through our website : https://www.bizwitresearch.com/service/syndicate-research-reports/healthcare/
Global CRISPR market is valued approximately USD 248 million in 2015. The growth is primarily driven by the rising demand for drug discovery and a significant rise in research spending. For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com
Global Healthcare Cloud Computing market was valued approximately USD 4.5 billion in 2016, is anticipated to grow USD 15.8 billion by 2025. The huge growth is driven by various factors such as rising demand for minimally invasive surgeries, growth in medical tourism, the rapid shift towards personalized care and so on.
Global ENT Devices industry valued approximately USD 17.75 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.45% over the forecast period 2017-2025. The prominent factors driving the market are growing elderly population, increasing number of incidents of long-term sinusitis, escalating implementation of minimally invasive ENT procedures, satisfactory compensation setting for ENT procedures in most of the developed countries, technological innovations, and growing presence of major players in the ENT devices market.
Global Breast Biopsy Market valued approximately USD 475 Million in 2016 is anticipated to grow with a healthy growth rate of more than 10.2% over the forecast period 2017-2025. For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com
Global Personalized Medicine industry valued approximately USD 99.2 billion in 2016 is anticipated to grow with an accelerating growth rate of approx. 9.4% over the forecast period 2017-2025. The market is primarily driven by the rapid advancements in next-generation sequencing technologies and the rising R&D investments from both biotechnology and pharmaceutical companies in the sector. Some other driving factors include increasing the prevalence of cancer, rising healthcare expenditure and so on.
